Sign Up Today and Learn More About Fractyl Health Stock
Invest in or calculate the value of your shares in Fractyl Health or other pre-IPO companies through EquityZen's platform.
Fractyl Health Stock
Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.
About Fractyl Health Stock
Founded
2010
Headquarters
Lexington, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with better solutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers. Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease.
Fractyl Health Press Mentions
Stay in the know about the latest news on Fractyl Health
Alto Neuroscience, Fractyl Health Join IPO Surge with Detailed Offering Plans
biospace • Feb 05, 2024
'Watershed moment': Obesity care in the spotlight as more ...
healio • Jan 19, 2024
Six diabetes biotech companies looking beyond insulin
labiotech • Jan 19, 2024
Wells Fargo gains ground in trading push
ifre • Jan 19, 2024
Fractyl Health announces new research on GLP-1-based pancreatic gene
bioworld • Nov 19, 2023
Fractyl Health Management
Leadership team at Fractyl Health
Co-Founder & CEO
Harith Rajagopalan
Co-founder & President
Jay Caplan
Join now and verify your accreditation status to gain access to:
- Fractyl Health current valuation
- Fractyl Health stock price
- Available deals in Fractyl Health and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Fractyl Health stock?
Accredited investors can buy pre-IPO stock in companies like Fractyl Health through EquityZen funds. These investments are made available by existing Fractyl Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Fractyl Health stock?
Shareholders can sell their Fractyl Health stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
